Health · Healthcare & Policy · 6 hrs ago
Health ministry asked to examine coronary stent safety concerns
India’s cabinet secretariat asked the health ministry to examine stent safety after a member of Parliament raised concerns.
The concerns involve three Indian-made coronary stent models reportedly withdrawn in Sri Lanka over quality issues.
Media reports cited possible problems including stents not expanding properly, shifting position or causing blood clots.
The MP urged India to review whether its rules and safety monitoring need strengthening.
He also called for better records, tracking of implanted devices and reporting of complications.
The ministry has been asked to take action, but no further steps are specified.
The cabinet secretariat asked the Union health ministry to act on concerns about the safety and quality of coronary stents.
The request followed a representation from Rajya Sabha member Ajeet Madhavrao Gopchade, who raised concerns about three India-made stent models reportedly withdrawn in Sri Lanka.
Reports cited problems including improper positioning, stent dislodgement, acute stent thrombosis and failure to expand properly.
Gopchade urged a review of India’s regulatory framework, device testing, clinical decisions and monitoring after implantation.
He also called for stent traceability, stronger adverse-event reporting and prompt review of foreign safety alerts.
- Who
- The cabinet secretariat asked the Union health ministry to act. Rajya Sabha member Ajeet Madhavrao Gopchade raised the concerns.
- What
- The ministry was asked to examine concerns over the safety and quality of coronary stents.
- When
- Gopchade sent his representation on September 29. The cabinet secretariat directed the health ministry on October 5.
- Where
- The representation was made to India’s cabinet secretariat. The three stent models were reportedly withdrawn in Sri Lanka.
- Why
- Gopchade cited reported quality and patient-safety concerns involving three India-made drug-eluting stent models.
This story does not have two clearly opposing sides.
Gopchade sent a representation to the cabinet secretariat raising concerns about coronary stent safety.
The cabinet secretariat directed the health ministry to take action on the concerns.
- Models cited
- Three India-made drug-eluting coronary stent models
- Reported withdrawal
- Sri Lanka
- Representation date
- September 29
- Direction date
- October 5
- Member
- Ajeet Madhavrao Gopchade
What people are saying
These reports highlight certain patient-safety issues that India needs to examine carefully and address proactively